rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
1999-10-15
|
pubmed:abstractText |
This study addresses the dynamic of viral load rebound and immune system changes in a cohort of eight consecutive HIV-1-infected patients in very early stages [all the patients were taking highly active antiretroviral therapy (HAART} and were recruited in the coordinating center from a larger study] who decided to discontinue HAART after 1 year of treatment and effective virologic response. The safety of this procedure and the outcome with reintroduction of the same treatment was also investigated.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0269-9370
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
30
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
F79-86
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10449278-Adult,
pubmed-meshheading:10449278-Anti-HIV Agents,
pubmed-meshheading:10449278-CD4-Positive T-Lymphocytes,
pubmed-meshheading:10449278-CD8-Positive T-Lymphocytes,
pubmed-meshheading:10449278-Cerebrospinal Fluid,
pubmed-meshheading:10449278-Drug Therapy, Combination,
pubmed-meshheading:10449278-Female,
pubmed-meshheading:10449278-HIV Infections,
pubmed-meshheading:10449278-HIV Protease Inhibitors,
pubmed-meshheading:10449278-HIV-1,
pubmed-meshheading:10449278-Humans,
pubmed-meshheading:10449278-Immunophenotyping,
pubmed-meshheading:10449278-Lamivudine,
pubmed-meshheading:10449278-Lymphocyte Activation,
pubmed-meshheading:10449278-Lymphoid Tissue,
pubmed-meshheading:10449278-Male,
pubmed-meshheading:10449278-Middle Aged,
pubmed-meshheading:10449278-RNA, Viral,
pubmed-meshheading:10449278-Reverse Transcriptase Inhibitors,
pubmed-meshheading:10449278-Ritonavir,
pubmed-meshheading:10449278-Stavudine,
pubmed-meshheading:10449278-Viral Load
|
pubmed:year |
1999
|
pubmed:articleTitle |
Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy.
|
pubmed:affiliation |
Infectious Diseases Unit, Institut d'Investigacions Biomèdiques August Pi I Sunyer Hospital Clínic, Faculty of Medicine, University of Barcelona, Spain.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|